Lusha

Website

lusha.com

Release Date

2016 January

Categories

#Sales Tools #Lead Generation #B2B #SaaS

Startup details

Country

United States

State

New York

City

New York

Founder(s)

Adi Weisz

Employees

100 - 249

Atomwise

Website

atomwise.com

Release Date

-

Categories

#AI #Productivity #SaaS #Health And Fitness

Lusha features and specs

• Accuracy
  Lusha provides highly accurate contact and company information, which can be vital for sales and marketing teams.
• Ease of Use
  The platform is user-friendly, and the browser extension makes it very convenient to access contact details directly from LinkedIn or other websites.
• Data Enrichment
  Lusha can enrich existing databases with additional information, making it easier to build comprehensive profiles of leads and contacts.
• GDPR Compliance
  Lusha is compliant with GDPR, which provides peace of mind for businesses operating in or dealing with customers in the EU.
• Integrations
  Lusha integrates seamlessly with various CRM systems, making it easier to manage and utilize the data within existing workflows.

Possible disadvantages of Lusha

• Cost
  Lusha can be expensive, especially for small businesses or startups with limited budgets.
• Data Privacy
  Despite GDPR compliance, some users may still have concerns regarding data privacy and the ethical implications of scraping contact information.
• Limited Database
  The database might not be as extensive as some competitors, potentially limiting the scope of accessible contact information.
• Credit System
  Lusha operates on a credit system for accessing information, which can be restrictive and may require additional purchases for extensive use.
• Occasional Inaccuracies
  Despite generally high accuracy, some users may encounter occasional outdated or incorrect information, especially in rapidly changing industries.

Atomwise features and specs

• AI-Driven Drug Discovery
  Atomwise uses deep learning and its AtomNet technology to predict small molecule binding to protein targets, significantly accelerating the early stages of drug discovery compared to traditional methods.
• Extensive Track Record
  The company has conducted hundreds of drug discovery programs with academic and pharmaceutical partners, building substantial experience across many disease areas including cancer, infectious diseases, and neurological disorders.
• Broad Partnership Network
  Atomwise has collaborated with numerous universities, biotech companies, and pharmaceutical firms worldwide, providing access to diverse expertise and expanding the reach of its technology platform.
• Cost and Time Efficiency
  By using computational screening instead of purely wet-lab experimentation, Atomwise can potentially reduce the time and cost associated with identifying viable drug candidates in early discovery phases.
• Large Compound Library Screening
  AtomNet can screen billions of compounds computationally, enabling exploration of chemical space that would be impractical or impossible using only physical screening methods.

Possible disadvantages of Atomwise

• Unproven Clinical Success
  While Atomwise has identified numerous drug candidates, the ultimate test of AI-discovered drugs is clinical success, and as of now, few if any of its discoveries have reached full FDA approval, making long-term efficacy claims uncertain.
• Dependency on Data Quality
  Like all AI models, AtomNet's predictions are only as good as the training data it uses; biases or gaps in structural and binding data can limit prediction accuracy for novel or understudied targets.
• High Competition
  The AI drug discovery space has become increasingly crowded with competitors like Insilico Medicine, Recursion Pharmaceuticals, and BenevolentAI, making it harder for Atomwise to maintain a distinct competitive advantage.
• Translational Gap
  Computational predictions of binding affinity do not always translate into actual biological efficacy or safety in living systems, meaning promising in-silico results can still fail in later preclinical or clinical testing.
• Limited Public Transparency
  As a private company, Atomwise does not always publicly disclose detailed data on program outcomes or success rates, making it difficult for outside parties to fully evaluate the effectiveness of its technology.

Analysis of Lusha

How to use Lusha

More videos:

No Atomwise videos yet. You could help us improve this page by suggesting one.

Add video